Showing results (61-70 of 100) with videos related to

Sort By:
Pageof 10
Nature Machine Intelligence|November 29, 2021
Radiological tumor classification across imaging modality and histologyJia Wu, Chao Li, Michael Gensheimer, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 15, 2018
Progress in the Management of Early-Stage Non-Small Cell Lung Cancer in 2017Jessica S Donington, Young Tae Kim, Betty Tong, et al.
Oncology|June 24, 2019
A Phase 1b/2 Study of the Bruton Tyrosine Kinase Inhibitor Ibrutinib and the PD-L1 Inhibitor Durvalumab in Patients with Pretreated Solid TumorsDavid Hong, Drew Rasco, Michael Veeder, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 20, 2016
Multicenter Phase II Study of Whole-Body and Intracranial Activity With Ceritinib in Patients With ALK-Rearranged Non-Small-Cell Lung Cancer Previously Treated With Chemotherapy and Crizotinib: Results From ASCEND-2Lucio Crinò, Myung-Ju Ahn, Filippo De Marinis, et al.
NPJ Precision Oncology|June 26, 2026
Redefining therapeutic horizons in thymic epithelial tumors: precision, combinations, and emerging biologyJennifer A Marks, Rohan Maniar, Kavitha J Ramchandran, et al.
Clinical Lung Cancer|December 1, 2023
Personalized Accelerated ChEmoRadiation (PACER) for Lung Cancer: Protocol for a Bayesian Optimal Phase I/II TrialCaressa Hui, Eleanor Brown, Samantha Wong, et al.
Journal of Neuro-Oncology|October 13, 2022
Local control of brain metastases with osimertinib alone in patients with EGFR-mutant non-small cell lung cancerCaressa Hui, Vera Qu, Jen-Yeu Wang, et al.
Cancer Cell|May 20, 2020
TERAVOLT: Thoracic Cancers International COVID-19 CollaborationJennifer G Whisenant, Annalisa Trama, Valter Torri, et al.
Lancet (London, England)|September 22, 2009
Oestrogen plus progestin and lung cancer in postmenopausal women (Women's Health Initiative trial): a post-hoc analysis of a randomised controlled trialRowan T Chlebowski, Ann G Schwartz, Heather Wakelee, et al.
Journal for Immunotherapy of Cancer|October 30, 2023
Comparison of SP263 and 22C3 immunohistochemistry PD-L1 assays for clinical efficacy of adjuvant atezolizumab in non-small cell lung cancer: results from the randomized phase III IMpower010 trialCaicun Zhou, Minu K Srivastava, Hao Xu, et al.
Pageof 10